Sign In
Buy BIOC
$0.435
+0 (+0%)
At Close: Jan 23, 2024
Direktur CTC: Polusi plastik ancam segitiga terumbu karang
09:00am, Wednesday, 07'th Oct 2020
Direktur Eksekutif Coral Triangle Center (CTC), Rili Djohani mengatakan bahwa polusi plastik, perubahan iklim, penangkapan ikan dan pariwisata yang tidak ...
BrightView Acquires Commercial Tree Care, Inc.
12:00am, Wednesday, 07'th Oct 2020
BrightView Acquires Commercial Tree Care, Inc. Purchase Follows Sale of BrightView Tree Company
Die ISET® Technologie identifizierte bei der Anwendung auf DLA-Produkte bei NSCLC-Patienten mehr CTC als andere Systeme
07:01am, Tuesday, 06'th Oct 2020
Rarecells Diagnostics (Frankreich), ein führendes Unternehmen der Flüssigbiopsie-Branche freut sich bekanntzugeben, dass das University Medical Center of Groningen, Niederlande, Forschungsergebnisse
Liquid Biopsy Market | COVID-19 Recovery and Growth Opportunities | Technavio
12:00am, Thursday, 24'th Sep 2020
The Global Liquid Biopsy Market will grow by $ 4.02 bn during 2020-2024
Tyme Technologies: Killing Cancer By Compromising Tumor Cell Metabolism (NASDAQ:TYME)
04:14pm, Wednesday, 23'rd Sep 2020
Tyme has a solid product candidate in pancreatic cancer. The company has no debt, strong IP, good insider interest.
Today's Hot Mover: Biocept, Inc. (NASDAQ:BIOC), Verona Pharma plc (NASDAQ:VRNA) - Stocks Equity
06:00am, Friday, 18'th Sep 2020
Biocept, Inc. (NASDAQ:BIOC) with the stream of -6.61% also noticed, India Verona Pharma plc (NASDAQ:VRNA) encountered a rapid change of -2.02% in the last hour of Thursday’s trading session. Biocept
CTC Global Names Enos Banda Managing Director
12:00am, Monday, 14'th Sep 2020
Today, CTC Global announced that Enos Banda has been named Managing Director. In this newly created position, Mr. Banda will lead the development and
Biocept (BIOC) Investor Presentation - Slideshow
02:34pm, Friday, 11'th Sep 2020
The following slide deck was published by Biocept, Inc. in conjunction with this event..
Biocept Expands Agreement with MultiPlan to Include COVID-19 Testing
12:00pm, Wednesday, 19'th Aug 2020
SAN DIEGO, Aug. 19, 2020 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular technologies designed to provide physicians with clinically actionable information
Aegea Biotechnologies, Inc. (www.aegeabiotech.com, "Aegea"), a biotechnology company focusing on the development and commercialization of next generation nucleic acid and clinical diagnostic technolog
Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients, announces
Can Biocept Stock Soar Over 100%? 5-Star Analyst Thinks So
11:38pm, Monday, 17'th Aug 2020
While so many businesses have suffered at the hands of COVID-19, Maxim analyst Jason McCarthy believes diagnostics specialist Biocept (BIOC) has managed to turn the narrative on its head and will exit
Biocept Announces Agreement with Healthcare Group to Provide COVID-19 Testing to Multi-State Locations
12:00pm, Thursday, 13'th Aug 2020
Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular technologies designed to provide physicians with clinically actionable information to improve outcomes, announces it has entere
Biocept Reports Second Quarter 2020 Financial Results
08:05pm, Wednesday, 12'th Aug 2020
Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular technologies designed to provide physicians with clinically actionable information to improve the outcomes of patients, reports financial
The Week Ahead In Biotech: Bausch Health, Fennec Pharma FDA Decisions And Smid-cap Earnings
12:00am, Sunday, 09'th Aug 2020
Biotech stocks advanced in the week ended Aug. 7, buoyed by multiple catalysts. Aside from the broader market strength, mostly positive earnings and continuing coronavirus...
